Study Stopped
Organisation problem
Motorized Platform and Autonomy Among the Frail and Pre-frail Older Adult (PLATAUTONOMIE)
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
Highly diversified programs of physical activity in older people have shown their effectiveness in terms of improving functional capacities. Only one of these programs, to date, has used a motorized platform. The motorized platform allows the use of sensorimotor programs adapted to this population. Thus, for the user, a combination of motor and sensory capacities necessary to actively control different positions as well as reactions to maintain balance are stimulated, and are as important as psychomotor capabilities to maintain autonomy and the fight against losing independence. Demonstration of the effectiveness of this type of equipment would propose a new modality of physical activity adapted to this population. Use of this new equipment could allow the possibility of standardizing this activity, whilst continuing to individualize physical activity programs. Two phases for each group (Intervention/Control): Phase 1 (day 0 - week 6): 2x1 hour sessions per week using the Hu360® (Intervention group) or an adapted physical activity program (Control group) under supervision of a therapist who will adapt the program according to the progress of the patient, following a standardized procedure (exercises: postural/balance training, strength training for the legs/trunk and coordination and endurance activities) Phase 2 (week 6 - month 6): Physical activity program at home for both groups, performed independently. Blinded evaluations will be performed at 6 weeks and at 6 months for each group. The investigators hypothesis is that the use of the motorized platform will allow superior physical performance compared to a traditional physical activity program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2019
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 20, 2016
CompletedFirst Posted
Study publicly available on registry
August 1, 2016
CompletedStudy Start
First participant enrolled
June 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedNovember 12, 2020
November 1, 2020
2.5 years
July 20, 2016
November 9, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Evolution of physical performances using the Score Short Physical Performance Battery
Evolution of physical performances within 6 months estimated by the Score Short Physical Performance Battery
6 months
Study Arms (2)
plate-forme Hu360®
EXPERIMENTALthe innovative technology (plate-forme Hu360®) will be used in the experimental arm
supervision by a therapist
NO INTERVENTIONan adapted physical activity program under supervision of a therapist
Interventions
the innovative technology (plate-forme Hu360®) will be used in the experimental arm
Eligibility Criteria
You may qualify if:
- Subjects aged between 70-89 years old.
- Living at home
- Having at least one fragility criteria (from Fried's 5 criteria), which must include the sedentary criteria.
- Having a Score SPPB \<10
- Independent mobility
- MMSE score ≥18
- BMI between 18 and 40
- Informed consent to participate in a randomized control trial (physical activity using the motorized platform, Hu360® vs a traditional physical activity program).
You may not qualify if:
- Severe cardiac problems
- Degenerative neurological conditions
- Hip/Knee joint replacement less than 6 months before the study.
- Psychotic disorders or bipolar disorder.
- Patients who already participate in a regular physical activity program or follow a rehabilitation program.
- Patients under legal protection and / or unable to give informed consent
- Already participating in a clinical trial or a study with a physical activity program.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Pierre Carette, PhD
University Hospital, Toulouse
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 20, 2016
First Posted
August 1, 2016
Study Start
June 1, 2019
Primary Completion
December 1, 2021
Study Completion
December 1, 2022
Last Updated
November 12, 2020
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share